Publicaciones (25) Publicaciones de COVADONGA ÁLVAREZ ÁLVAREZ

2024

  1. Topical Meloxicam Hydroxypropyl Guar Hydrogels Based on Low-Substituted Hydroxypropyl Cellulose Solid Dispersions

    Gels, Vol. 10, Núm. 3

2022

  1. Multiparticulate Systems of Meloxicam for Colonic Administration in Cancer or Autoimmune Diseases

    Pharmaceutics, Vol. 14, Núm. 7

2021

  1. Desarrollo de una IVIVC basada en disolución dinámica en el aparato USP IV aplicada a diferentes formulaciones de Montelukast

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 241-242

  2. Geles para administración tópica de meloxicam: velocidad de disolución a pH=5,8

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 141-142

  3. One and two-step in vitro-in vivo correlations based on usp iv dynamic dissolution applied to four sodium montelukast products

    Pharmaceutics, Vol. 13, Núm. 5

2019

  1. Enhancement of the Dissolution Rate of Indomethacin by Solid Dispersions in Low-substituted Hydroxypropyl Cellulose

    Indian Journal of Pharmaceutical Sciences, Vol. 81, Núm. 5, pp. 824-833

  2. Investigation on the Existence of Sex-By-Formulation Interaction in Bioequivalence Trials

    Clinical Pharmacology and Therapeutics, Vol. 106, Núm. 5, pp. 1099-1112

  3. Sex-by-formulation interaction in bioequivalence trials with transdermal patches

    European Journal of Clinical Pharmacology, Vol. 75, Núm. 6, pp. 801-808

2018

  1. Evaluation of sex-by-formulation interaction in bioequivalence studies of efavirenz tablets

    British Journal of Clinical Pharmacology, Vol. 84, Núm. 8, pp. 1729-1737

2017

  1. IVIVC approach based on carbamazepine bioequivalence studies combination

    Pharmazie, Vol. 72, Núm. 8, pp. 449-455

2016

  1. New Multi-Particle Systems for Colon-Targeted Meloxicam

    Journal of Applied Pharmacy, Vol. 8, Núm. 3, pp. 1-3

2015

  1. Agitation Rate and Time for Complete Dissolution in BCS Biowaivers Based on Investigation of a BCS Biowaiver for Dexketoprofen Tablets

    Molecular Pharmaceutics, Vol. 12, Núm. 9, pp. 3194-3201

  2. Validated RP-HPLC Method for Simultaneous Amoxicillin and Meloxicam Determination in Combined Dosage Forms

    Journal of Pharma Research, Vol. 4, Núm. 11, pp. 355-660

2013

  1. Bioequivalence between generic tacrolimus products marketed in Spain by adjusted indirect comparison

    European Journal of Clinical Pharmacology, Vol. 69, Núm. 5, pp. 1157-1162

2012

  1. Differences in lercanidipine systemic exposure when administered according to labelling: In fasting state and 15 minutes before food intake

    European Journal of Clinical Pharmacology, Vol. 68, Núm. 7, pp. 1043-1047

  2. Investigation on the need of multiple dose bioequivalence studies for prolonged-release generic products

    International Journal of Pharmaceutics, Vol. 423, Núm. 2, pp. 321-325

  3. Review of oral insulin delivery systems

    European Journal of Parenteral and Pharmaceutical Sciences, Vol. 17, Núm. 1, pp. 20-26

2011

  1. Investigation on the possibility of biowaivers for ibuprofen

    Journal of Pharmaceutical Sciences, Vol. 100, Núm. 6, pp. 2343-2349

2010

  1. Consejo farmacéutico en dermoprotección solar infantil

    Farmacéuticos comunitarios, Vol. 2, Núm. 2, pp. 67-73

2009

  1. Development of an automatic solid phase extraction and liquid chromatography mass spectrometry method by using a monolithic column for the analysis of Cyclosporin A in human plasma

    Talanta, Vol. 79, Núm. 2, pp. 280-283